Royalty Pharma plc (RPRX)
USD 29.97
(-3.66%)
USD 29.97
(-3.66%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.88 Billion USD | 51.77% |
| 2022 | 928.56 Million USD | -33.66% |
| 2021 | 1.45 Billion USD | -21.25% |
| 2020 | 1.68 Billion USD | -28.64% |
| 2019 | 2.64 Billion USD | 86.56% |
| 2018 | 1.39 Billion USD | 23.8% |
| 2017 | 972.95 Million USD | 44.35% |
| 2016 | 1.06 Billion USD | -8.27% |
| 2015 | 862.43 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -73.77 Million USD | -94.07% |
| 2024 Q2 | 269.63 Million USD | 1301.44% |
| 2023 Q1 | 527.46 Million USD | 212.1% |
| 2023 Q4 | 613 Million USD | 264.99% |
| 2023 Q2 | 274.81 Million USD | -47.9% |
| 2023 FY | - USD | 51.77% |
| 2023 Q3 | 167.94 Million USD | -38.89% |
| 2022 FY | - USD | -33.66% |
| 2022 Q4 | 169 Million USD | -12.07% |
| 2022 Q3 | 192.19 Million USD | -50.52% |
| 2022 Q2 | 388.41 Million USD | 66.3% |
| 2022 Q1 | 233.55 Million USD | 83.89% |
| 2021 Q3 | 323.06 Million USD | -58.7% |
| 2021 Q4 | 127.01 Million USD | -60.69% |
| 2021 Q1 | 249.69 Million USD | -39.25% |
| 2021 FY | - USD | -21.25% |
| 2021 Q2 | 782.31 Million USD | 213.31% |
| 2020 Q3 | 661 Million USD | 47.76% |
| 2020 Q1 | 355.02 Million USD | -73.31% |
| 2020 FY | - USD | -28.64% |
| 2020 Q4 | 411 Million USD | -37.82% |
| 2020 Q2 | 447.35 Million USD | 26.01% |
| 2019 Q1 | 442.05 Million USD | 0.0% |
| 2019 FY | - USD | 86.56% |
| 2019 Q4 | 1.33 Billion USD | 148.62% |
| 2019 Q3 | 535.06 Million USD | 62.2% |
| 2019 Q2 | 329.88 Million USD | -25.37% |
| 2018 FY | - USD | 23.8% |
| 2017 FY | - USD | 44.35% |
| 2016 FY | - USD | -8.27% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | 1082.148% |
| Alkermes plc | 495.04 Million USD | -281.23% |
| Agenus Inc. | -145.92 Million USD | 1393.327% |
| Aptorum Group Limited | -9.59 Million USD | 19761.169% |
| Ardelyx, Inc. | -55.35 Million USD | 3509.465% |
| Dyadic International, Inc. | -8.22 Million USD | 23032.38% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | 648648.11% |
| Lantern Pharma Inc. | -15.78 Million USD | 12054.85% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | 9577.891% |
| Novavax, Inc. | -487.39 Million USD | 487.221% |
| Janux Therapeutics, Inc. | -71.02 Million USD | 2757.236% |
| Pyxis Oncology, Inc. | -78.49 Million USD | 2504.386% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | 10600.349% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | 19033.337% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | 3389.315% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 596.692% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 7927.152% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | -356662.76% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | 1300.595% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | 2622.593% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 9461.948% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | 8051.443% |
| Clearside Biomedical, Inc. | -23.05 Million USD | 8284.903% |
| C4 Therapeutics, Inc. | -122.1 Million USD | 1645.642% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 830.816% |
| AlloVir, Inc. | -190.14 Million USD | 1092.54% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | 1174.317% |
| VYNE Therapeutics Inc. | -29.25 Million USD | 6550.458% |
| Bicycle Therapeutics plc | -183.4 Million USD | 1129.049% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | 1240.892% |
| ChromaDex Corporation | -3.89 Million USD | 48566.23% |
| Chimerix, Inc. | -92.97 Million USD | 2129.895% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | 4347.109% |
| Caribou Biosciences, Inc. | -112.53 Million USD | 1777.071% |
| CRISPR Therapeutics AG | -202.7 Million USD | 1031.063% |
| Precision BioSciences, Inc. | -32.04 Million USD | 5990.004% |
| Fate Therapeutics, Inc. | -172.22 Million USD | 1195.794% |
| Fortress Biotech, Inc. | -133.64 Million USD | 1512.176% |
| Fortress Biotech, Inc. | -133.64 Million USD | 1512.176% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | 2540.137% |
| ImmuCell Corporation | -2.5 Million USD | 75468.09% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | 1547.064% |
| Immix Biopharma, Inc. | -16.13 Million USD | 11796.31% |
| Incyte Corporation | 919.42 Million USD | -105.267% |
| Innoviva, Inc. | 248.96 Million USD | -658.064% |
| IO Biotech, Inc. | -91.22 Million USD | 2168.745% |
| Jaguar Health, Inc. | -33.13 Million USD | 5796.402% |
| Keros Therapeutics, Inc. | -152.17 Million USD | 1340.184% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | -1755.235% |
| ContextLogic Inc. | -324 Million USD | 682.492% |
| MiMedx Group, Inc. | 40.51 Million USD | -4557.983% |
| MEI Pharma, Inc. | 26.38 Million USD | -7054.189% |
| NextCure, Inc. | -59.03 Million USD | 3296.658% |
| Onconetix, Inc. | -36.7 Million USD | 5241.497% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | -84341.834% |
| Opthea Limited | -200.01 Million USD | 1043.549% |
| Psyence Biomedical Ltd. | -2.75 Million USD | 68688.774% |
| Vaxcyte, Inc. | -464.88 Million USD | 505.966% |
| PDS Biotechnology Corporation | -40.08 Million USD | 4808.186% |
| Precigen, Inc. | -89.22 Million USD | 2215.163% |
| Pharming Group N.V. | 9.87 Million USD | -19007.776% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | 1286.6% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | 8391.341% |
| PureTech Health plc | -11.62 Million USD | 16331.831% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | 11214.039% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 908.265% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 7927.152% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | 2258.687% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | 6616.159% |
| Acelyrin, Inc. | -381.52 Million USD | 594.665% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | 14647295.281% |
| Summit Therapeutics Inc. | 1 Million USD | -188438.961% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | 5752.893% |
| Senti Biosciences, Inc. | -61.33 Million USD | 3176.945% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | 1780.506% |
| Elevation Oncology, Inc. | -41.46 Million USD | 4651.27% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | 6206.896% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | 30955.241% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | 588036.137% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | 5915.41% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | 22578.263% |
| Wave Life Sciences Ltd. | -58.79 Million USD | 3310.197% |
| Seer, Inc. | -97.88 Million USD | 2028.053% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | 3134.351% |
| Aadi Bioscience, Inc. | -65.36 Million USD | 2987.287% |
| ESSA Pharma Inc. | -26.45 Million USD | 7233.823% |
| GlycoMimetics, Inc. | -39.12 Million USD | 4924.077% |
| GT Biopharma, Inc. | 5.97 Million USD | -31465.061% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 1013.081% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | 27579.252% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | -2073.979% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | 3425.36% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | 3784.717% |
| Alzamend Neuro, Inc. | -9.88 Million USD | 19188.633% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 449.542% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | 27515.383% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | 4127.304% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 897.591% |
| Aptose Biosciences Inc. | -52.26 Million USD | 3710.766% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | 1851.639% |
| Soligenix, Inc. | -7.85 Million USD | 24132.994% |
| Century Therapeutics, Inc. | -121.2 Million USD | 1657.055% |
| Kura Oncology, Inc. | -164.95 Million USD | 1244.115% |
| TScan Therapeutics, Inc. | -80.09 Million USD | 2456.207% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | 18811.828% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | 197155.252% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | 43898.445% |
| Autolus Therapeutics plc | -156.77 Million USD | 1303.85% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | 2329.319% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | 2835.142% |
| Eterna Therapeutics Inc. | -19.93 Million USD | 9567.618% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | 1097.118% |
| GRI Bio, Inc. | -10.89 Million USD | 17417.627% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | 41893.492% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | 1640.557% |
| IGM Biosciences, Inc. | -253.35 Million USD | 844.904% |
| INmune Bio, Inc. | - USD | -Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | 1918.324% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 5049.163% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 12410.263% |
| Entero Therapeutics, Inc. | -15.74 Million USD | 12087.842% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | 3420.037% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | 1862.112% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 809.51% |
| Coherus BioSciences, Inc. | -193.93 Million USD | 1073.128% |
| Verastem, Inc. | -83.16 Million USD | 2369.287% |
| Abeona Therapeutics Inc. | -50.57 Million USD | 3831.858% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | 1292.757% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | 1754.213% |
| Histogen Inc. | -10.5 Million USD | 18068.914% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | 13316.482% |
| Surrozen, Inc. | -41.13 Million USD | 4688.449% |
| Organovo Holdings, Inc. | -14.8 Million USD | 12846.691% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -58848512.41% |
| Ovid Therapeutics Inc. | -58.71 Million USD | 3314.397% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 3779.329% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | 8862.129% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | 22734.611% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | 1236.459% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | 3931.372% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | 7909.629% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | 12635.836% |
| Apollomics, Inc. | -171.74 Million USD | 1198.869% |
| Amarin Corporation plc | -50.9 Million USD | 3807.698% |
| Mesoblast Limited | -61.33 Million USD | 3177.196% |
| Turnstone Biologics Corp. | -56.23 Million USD | 3456.11% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | 1417.92% |
| Synaptogenix, Inc. | -8.3 Million USD | 22817.706% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | 12403.768% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | 3093.441% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 39488.258% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | -439784.253% |
| Exelixis, Inc. | 196.6 Million USD | -859.947% |
| Better Therapeutics, Inc. | -38.26 Million USD | 5032.505% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | 1434.622% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 481.105% |
| NLS Pharmaceutics AG | -11.79 Million USD | 16099.747% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | -763311.349% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | 6496.241% |
| Gritstone bio, Inc. | -126.86 Million USD | 1587.648% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 3004.17% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 47282.512% |
| Avid Bioservices, Inc. | -11.48 Million USD | 16538.246% |
| Insmed Incorporated | -654.73 Million USD | 388.248% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | 83989.366% |
| MediWound Ltd. | -4.89 Million USD | 38670.918% |
| OmniAb, Inc. | -49.73 Million USD | 3894.967% |
| Alector, Inc. | -142.89 Million USD | 1420.77% |
| Seres Therapeutics, Inc. | -85.43 Million USD | 2309.044% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | 3719.075% |
| Zai Lab Limited | -366.57 Million USD | 614.843% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 749.358% |
| Aura Biosciences, Inc. | -83.69 Million USD | 2354.917% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 937.862% |
| Immunic, Inc. | -99.11 Million USD | 2004.184% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | 1533.337% |
| Veracyte, Inc. | -49.4 Million USD | 3919.699% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | 26817.064% |
| FibroGen, Inc. | -261.4 Million USD | 821.974% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 17039.907% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 27055.957% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | 10183.285% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | -30.209% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | 7523.786% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | -4631.198% |
| TG Therapeutics, Inc. | 26.1 Million USD | -7130.939% |
| Galecto, Inc. | -37.51 Million USD | 5130.185% |
| Calithera Biosciences, Inc. | -38.26 Million USD | 5032.118% |
| Fortrea Holdings Inc. | 167.3 Million USD | -1028.078% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | 1505.477% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | 6766.225% |
| XBiotech Inc. | -35.76 Million USD | 5376.729% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 3004.17% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | 2992.375% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | 1906.783% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | 7451.492% |
| Theravance Biopharma, Inc. | -40.86 Million USD | 4718.09% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 465.429% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | 3468.871% |
| Vaxxinity, Inc. | -56.05 Thousand USD | 3367167.492% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | 1722.276% |
| Gain Therapeutics, Inc. | -22.16 Million USD | 8612.914% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 902.877% |
| NexImmune, Inc. | -28.16 Million USD | 6800.184% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | 34255.436% |
| Marker Therapeutics, Inc. | -11.79 Million USD | 16104.337% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 59.45% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | 7532.557% |
| Scopus BioPharma Inc. | -11.71 Million USD | 16212.448% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | 1599.67% |
| Ainos, Inc. | -8.77 Million USD | 21612.07% |
| Pluri Inc. | -20.22 Million USD | 9431.397% |
| Prothena Corporation plc | -190.1 Million USD | 1092.738% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | 1572.156% |
| Celularity Inc. | -183.94 Million USD | 1125.994% |
| Rallybio Corporation | -72.37 Million USD | 2707.706% |
| Cue Biopharma, Inc. | -46.05 Million USD | 4198.139% |
| MeiraGTx Holdings plc | -57.05 Million USD | 3407.991% |
| Omeros Corporation | -163.61 Million USD | 1253.521% |
| Humacyte, Inc. | -96.45 Million USD | 2056.577% |
| Immunocore Holdings plc | -59.64 Million USD | 3263.968% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | 9842.283% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | 7845.844% |
| Blueprint Medicines Corporation | -474.61 Million USD | 497.646% |
| CalciMedica, Inc. | -34.18 Million USD | 5620.123% |
| Cabaletta Bio, Inc. | -73.23 Million USD | 2677.048% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | 1603.841% |
| Scholar Rock Holding Corporation | -168.45 Million USD | 1220.37% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 847.761% |
| Pulmatrix, Inc. | -12.64 Million USD | 15023.889% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | 5824.914% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | 2233.31% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 472.747% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | 1964.62% |
| Cytokinetics, Incorporated | -456.68 Million USD | 513.256% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | 5755.095% |
| Nutriband Inc. | -5.12 Million USD | 36948.051% |
| Protara Therapeutics, Inc. | -43.27 Million USD | 4461.423% |
| Vor Biopharma Inc. | -114.37 Million USD | 1750.134% |
| Roivant Sciences Ltd. | -996.51 Million USD | 289.388% |
| Evogene Ltd. | -23.2 Million USD | 8233.404% |
| ProKidney Corp. | -147.66 Million USD | 1378.044% |
| Applied Therapeutics, Inc. | -64.53 Million USD | 3024.421% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | 1232412.976% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 433.755% |
| CorMedix Inc. | -48.88 Million USD | 3960.482% |
| BioLineRx Ltd. | -57.06 Million USD | 3407.469% |
| Tango Therapeutics, Inc. | -111.75 Million USD | 1788.716% |
| Galectin Therapeutics Inc. | -202 Thousand USD | 934394.554% |
| Atai Life Sciences N.V. | -36.31 Million USD | 5297.53% |
| Renovaro Biosciences Inc. | -79.51 Million USD | 2473.424% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | 2421.0% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 785.029% |
| Sagimet Biosciences Inc. | -30.74 Million USD | 6239.476% |
| MediciNova, Inc. | -9.87 Million USD | 19202.032% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | 1598.539% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 123435.104% |
| GeoVax Labs, Inc. | -26.66 Million USD | 7176.723% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 938.822% |
| Biomea Fusion, Inc. | -124.62 Million USD | 1614.424% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 671.313% |
| Mereo BioPharma Group plc | -26.05 Million USD | 7343.149% |
| Cullinan Oncology, Inc. | -190.33 Million USD | 1091.534% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 920.761% |
| Absci Corporation | -95.45 Million USD | 2077.094% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 6385.679% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | 1861.865% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 908.338% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | 8357.602% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 1008.06% |
| Allakos Inc. | -189.91 Million USD | 1093.747% |
| Imunon, Inc. | -19.87 Million USD | 9594.157% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | 1839.552% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | -1642.25% |
| BioAtla, Inc. | -122.24 Million USD | 1643.897% |
| NLS Pharmaceutics AG | -11.79 Million USD | 16099.747% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | 12074.335% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 728.478% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | 4653.466% |
| XOMA Corporation | -39.36 Million USD | 4894.662% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | 2001.46% |
| Cara Therapeutics, Inc. | -117.65 Million USD | 1704.144% |
| aTyr Pharma, Inc. | -52.17 Million USD | 3716.994% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | 2351.715% |
| Akero Therapeutics, Inc. | -148.63 Million USD | 1369.772% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 904.585% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | 13923.152% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | 23566.856% |
| Akari Therapeutics, Plc | -16.8 Million USD | 11332.443% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -1000013.934% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | -317.588% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 29641.177% |
| UroGen Pharma Ltd. | -63.83 Million USD | 3056.675% |
| Sutro Biopharma, Inc. | -67.91 Million USD | 2878.878% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | 26084.743% |
| Orgenesis Inc. | -60.71 Million USD | 3208.263% |
| Entera Bio Ltd. | -8.8 Million USD | 21536.563% |
| GH Research PLC | -41.15 Million USD | 4685.996% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | 7495.568% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | 2395.034% |
| Xencor, Inc. | -125.87 Million USD | 1599.337% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | 132396.913% |
| Replimune Group, Inc. | -230.19 Million USD | 919.849% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | 9462.589% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | 17347.989% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 29641.177% |
| Portage Biotech Inc. | -18.19 Million USD | 10470.213% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 123435.104% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | 1904.554% |
| OncoCyte Corporation | -23.12 Million USD | 8261.895% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | 16801.014% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | 16572.912% |
| Purple Biotech Ltd. | -22.22 Million USD | 8591.676% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | 29542.668% |
| scPharmaceuticals Inc. | -46.06 Million USD | 4197.338% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | 10696.905% |
| HilleVax, Inc. | -132.46 Million USD | 1524.724% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | 17849.224% |
| Tharimmune, Inc. | -9.3 Million USD | 20387.632% |
| Genprex, Inc. | -31.06 Million USD | 6176.113% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | 1106.407% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | 6119.248% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | 247125.524% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | -1250546.106% |
| OKYO Pharma Limited | -15.74 Thousand USD | 11985941.367% |
| Savara Inc. | -59.13 Million USD | 3291.577% |
| Curis, Inc. | -45.13 Million USD | 4281.03% |
| Daré Bioscience, Inc. | -30.7 Million USD | 6247.172% |
| Carmell Therapeutics Corporation | -15.19 Million USD | 12523.518% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | 26440.195% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | 7159.456% |
| BeiGene, Ltd. | -1.12 Billion USD | 267.816% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | 11677.522% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 538.308% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | 2189.08% |
| Erasca, Inc. | -121.31 Million USD | 1655.746% |
| bluebird bio, Inc. | -167.16 Million USD | 1229.016% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 42051.042% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | -508.241% |
| DBV Technologies S.A. | -85.98 Million USD | 2294.965% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 42051.042% |
| Moderna, Inc. | -3.28 Billion USD | 157.486% |
| Vincerx Pharma, Inc. | -42.6 Million USD | 4529.287% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | 33514.926% |
| Molecular Templates, Inc. | 1.43 Million USD | -131877.273% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | 3253.236% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 678.482% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | 1476.679% |
| Spruce Biosciences, Inc. | -47.36 Million USD | 4084.451% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | 1457.42% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 1016.776% |
| MacroGenics, Inc. | 2.01 Million USD | -93468.418% |
| RenovoRx, Inc. | -11.39 Million USD | 16669.579% |
| Adicet Bio, Inc. | -136.53 Million USD | 1482.265% |
| Prime Medicine, Inc. | -193.75 Million USD | 1074.032% |
| Aditxt, Inc. | -25.45 Million USD | 7513.299% |
| Adagene Inc. | -14.95 Million USD | 12723.25% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 25917.369% |
| Quantum-Si incorporated | -91.8 Million USD | 2155.766% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | -164.915% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | -1392.448% |
| SciSparc Ltd. | -5.28 Million USD | 35830.31% |
| Vericel Corporation | 2.86 Million USD | -65796.473% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 1982365.146% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | 8800.556% |
| Generation Bio Co. | -133.3 Million USD | 1515.81% |
| Astria Therapeutics, Inc. | -83.03 Million USD | 2373.004% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | 2293.919% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 929.812% |
| Invivyd, Inc. | -196.61 Million USD | 1059.884% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 604.413% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | 20448.422% |
| Spero Therapeutics, Inc. | 27.15 Million USD | -6850.265% |
| Artelo Biosciences, Inc. | -10.28 Million USD | 18449.781% |
| 2seventy bio, Inc. | -206.41 Million USD | 1014.298% |
| ADMA Biologics, Inc. | 5.12 Million USD | -36760.84% |
| Clene Inc. | -43.24 Million USD | 4464.55% |
| Capricor Therapeutics, Inc. | -23 Million USD | 8302.342% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | 3993.135% |
| GeoVax Labs, Inc. | -26.66 Million USD | 7176.723% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 730.003% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | 5238.329% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | -7906.087% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | -38335.377% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | 5910.218% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | 1291.431% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 375.794% |
| Evaxion Biotech A/S | -21.4 Million USD | 8917.806% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | 2941.64% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 967.039% |
| Trevena, Inc. | -35.28 Million USD | 5448.206% |
| Surrozen, Inc. | -41.13 Million USD | 4688.449% |
| Tyra Biosciences, Inc. | -79.59 Million USD | 2471.187% |
| Cingulate Inc. | -22.95 Million USD | 8322.693% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | 25395.202% |
| Unity Biotechnology, Inc. | -37.28 Million USD | 5162.026% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | 23041.769% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | 1945.457% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | 2882.483% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | 3333.185% |
| Clearmind Medicine Inc. | -8.71 Million USD | 21766.262% |
| Kronos Bio, Inc. | -121.83 Million USD | 1649.105% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | 2638.639% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 77402.539% |
| Viking Therapeutics, Inc. | -100.82 Million USD | 1971.795% |
| Statera Biopharma, Inc. | 38.93 Million USD | -4747.251% |
| ImmunityBio, Inc. | -436.18 Million USD | 532.681% |
| Korro Bio, Inc. | -80.9 Million USD | 2432.734% |
| Kineta, Inc. | -15.71 Million USD | 12110.15% |
| BioVie Inc. | -31.95 Million USD | 6006.926% |
| Codexis, Inc. | -49.28 Million USD | 3929.465% |
| Celularity Inc. | -183.94 Million USD | 1125.994% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 952.004% |
| Celcuity Inc. | -58.3 Million USD | 3336.626% |
| Virax Biolabs Group Limited | -6.6 Million USD | 28655.513% |
| Cibus, Inc. | -314.58 Million USD | 699.925% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | 5694.744% |
| IN8bio, Inc. | -28.5 Million USD | 6721.088% |
| Kodiak Sciences Inc. | -259.02 Million USD | 828.613% |
| Annexon, Inc. | -141.57 Million USD | 1433.057% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | 1776.103% |
| Assembly Biosciences, Inc. | -64.19 Million USD | 3039.864% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | 6851.118% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 920.519% |
| Eyenovia, Inc. | -24.1 Million USD | 7929.056% |
| Puma Biotechnology, Inc. | 44.78 Million USD | -4114.172% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 582592.284% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | 2657.145% |
| Arcellx, Inc. | -64.14 Million USD | 3042.201% |
| Cardiff Oncology, Inc. | -45.01 Million USD | 4292.64% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | 1628.455% |
| Regulus Therapeutics Inc. | -30.88 Million USD | 6211.246% |
| Moolec Science SA | -52.07 Million USD | 3724.11% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | 3757.084% |
| Geron Corporation | -174.78 Million USD | 1179.788% |
| LAVA Therapeutics N.V. | -40.41 Million USD | 4769.508% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | 1678.081% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | 20340.493% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | 9199.355% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | 1236.365% |
| Humacyte, Inc. | -96.45 Million USD | 2056.577% |
| Structure Therapeutics Inc. | -102.45 Million USD | 1941.981% |
| 89bio, Inc. | -134.46 Million USD | 1503.565% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | 2492.742% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | -46476.382% |
| Genelux Corporation | -24.16 Million USD | 7909.952% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | 5683.654% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | 1254.551% |
| Notable Labs, Ltd. | -14.4 Million USD | 13206.076% |
| Liquidia Corporation | -70.05 Million USD | 2794.144% |
| Mustang Bio, Inc. | -48.06 Million USD | 4026.669% |
| Immunovant, Inc. | -269.97 Million USD | 799.048% |
| Quantum-Si incorporated | -91.8 Million USD | 2155.766% |
| Arbutus Biopharma Corporation | -70.98 Million USD | 2758.658% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | 9874.575% |
| Vera Therapeutics, Inc. | -102.01 Million USD | 1950.052% |
| Acasti Pharma Inc. | -11.3 Million USD | 16800.071% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | 8580.899% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 12410.263% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 996.512% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | 44294.928% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | 11984.603% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | 6658.504% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | 5196.611% |
| PepGen Inc. | -83.58 Million USD | 2357.992% |
| Moleculin Biotech, Inc. | -29.5 Million USD | 6496.675% |
| United Therapeutics Corporation | 1.38 Billion USD | -36.088% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 8342.455% |
| Solid Biosciences Inc. | -93.43 Million USD | 2119.902% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | 39651.119% |
| Immuneering Corporation | -58.06 Million USD | 3350.515% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -58848512.41% |
| Silo Pharma, Inc. | -3.62 Million USD | 52145.329% |
| Belite Bio, Inc | -31.52 Million USD | 6085.838% |
| XOMA Corporation | -39.36 Million USD | 4894.662% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | 2898.16% |
| Bionomics Limited | -9.83 Million USD | 19285.483% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 2347.157% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 5553.606% |
| uniQure N.V. | -253.1 Million USD | 845.664% |
| Cassava Sciences, Inc. | -95.68 Million USD | 2072.342% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 25917.369% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | 1557.31% |
| Forte Biosciences, Inc. | -32.47 Million USD | 5911.113% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | 23543.032% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | 6787.958% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 582592.284% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 17039.907% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | 11968.908% |
| Altimmune, Inc. | -87.93 Million USD | 2246.216% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | 2149.626% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 5553.606% |
| Compugen Ltd. | -12.51 Million USD | 15178.899% |
| Peak Bio, Inc. | -1356.23 USD | 139156069.12% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | 3983.442% |
| Benitec Biopharma Inc. | -22.49 Million USD | 8491.618% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 878.89% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | 6712.041% |
| Zura Bio Limited | -60.56 Million USD | 3216.218% |
| PolyPid Ltd. | -20.26 Million USD | 9413.897% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | 12187.843% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | 6712.041% |
| Instil Bio, Inc. | -146.12 Million USD | 1391.575% |
| argenx SE | -216.02 Million USD | 973.645% |
| Immunome, Inc. | -28.27 Million USD | 6775.657% |
| Compass Therapeutics, Inc. | -48.47 Million USD | 3993.456% |
| Verona Pharma plc | -52.46 Million USD | 3697.03% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | 2091.385% |
| Shattuck Labs, Inc. | -87.61 Million USD | 2254.055% |
| CervoMed Inc. | -2.17 Million USD | 86996.155% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | 1643.859% |
| Plus Therapeutics, Inc. | -12.69 Million USD | 14968.628% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | 4017.622% |
| Moolec Science SA | -52.07 Million USD | 3724.11% |
| Enveric Biosciences, Inc. | -17.13 Million USD | 11110.95% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | 1547.396% |
| AnaptysBio, Inc. | -143.16 Million USD | 1418.261% |
| Design Therapeutics, Inc. | -66.32 Million USD | 2945.496% |
| Leap Therapeutics, Inc. | -80.98 Million USD | 2430.343% |
| NeurAxis, Inc. | -6.66 Million USD | 28418.35% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | 5099.404% |
| Lumos Pharma, Inc. | -36.57 Million USD | 5260.719% |
| Achilles Therapeutics plc | -70.44 Million USD | 2779.19% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | 2091.385% |
| 180 Life Sciences Corp. | -22.13 Million USD | 8626.578% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | -32275.966% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 77402.539% |
| Nutriband Inc. | -5.12 Million USD | 36948.051% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | 1819.644% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | 3504.667% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | 3833.482% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | 2991.179% |
| MoonLake Immunotherapeutics | -54.1 Million USD | 3587.853% |
| Palisade Bio, Inc. | -12.28 Million USD | 15467.438% |
| Tourmaline Bio, Inc. | -45.37 Million USD | 4259.192% |
| Beam Therapeutics Inc. | -156.47 Million USD | 1306.135% |
| Neurogene Inc. | -52.28 Million USD | 3709.523% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | 1482.72% |
| AEON Biopharma, Inc. | -48.36 Million USD | 4002.473% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | 2128.935% |
| Sesen Bio, Inc. | -50.84 Million USD | 3812.185% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | 2403.465% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | 15381.55% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 541.538% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | 1894.039% |
| Athira Pharma, Inc. | -116.7 Million USD | 1717.161% |
| Vaccinex, Inc. | -19.74 Million USD | 9656.791% |
| HCW Biologics Inc. | -23.57 Million USD | 8105.05% |
| XOMA Corporation | -39.36 Million USD | 4894.662% |
| Nektar Therapeutics | -243.1 Million USD | 876.315% |
| Arvinas, Inc. | -394.8 Million USD | 578.033% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -1000013.934% |
| Merus N.V. | -149.2 Million USD | 1364.87% |
| Omega Therapeutics, Inc. | -93.49 Million USD | 2118.692% |
| Quince Therapeutics, Inc. | -31.26 Million USD | 6137.348% |
| Rezolute, Inc. | -68.42 Million USD | 2858.246% |
| Clene Inc. | -43.24 Million USD | 4464.55% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 12337.399% |
| BeyondSpring Inc. | -21.54 Million USD | 8861.722% |
| Synlogic, Inc. | -55.16 Million USD | 3521.394% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | 15719.258% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | 17834.213% |
| Peak Bio, Inc. | -1356.23 USD | 139156069.12% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | 5913.26% |
| Krystal Biotech, Inc. | 17.9 Million USD | -10441.08% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | 1693.673% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 652.892% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | 41070.43% |
| MannKind Corporation | 15.12 Million USD | -12374.552% |
| Ikena Oncology, Inc. | -74.39 Million USD | 2636.762% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | 15086.699% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | -9184.572% |
| Gossamer Bio, Inc. | -172.15 Million USD | 1196.284% |
| CohBar, Inc. | -12.06 Million USD | 15741.577% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | 7498.467% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 6385.679% |
| Legend Biotech Corporation | -477.87 Million USD | 494.932% |
| Mural Oncology plc | -192.72 Million USD | 1079.283% |
| Biora Therapeutics, Inc. | -114.05 Million USD | 1754.721% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | 11789.337% |
| Disc Medicine, Inc. | -91.02 Million USD | 2173.359% |
| Champions Oncology, Inc. | -5.05 Million USD | 37442.204% |
| REGENXBIO Inc. | -239.46 Million USD | 888.125% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | 17708.155% |
| Anavex Life Sciences Corp. | -55.75 Million USD | 3484.882% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | 4968.092% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | 1773.027% |
| Vaxart, Inc. | -74.72 Million USD | 2625.695% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | 5460.314% |
| Cellectis S.A. | -98.09 Million USD | 2023.926% |
| Longeveron Inc. | -20.06 Million USD | 9508.151% |
| Repare Therapeutics Inc. | -114.27 Million USD | 1751.549% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 529.711% |
| Inozyme Pharma, Inc. | -74.81 Million USD | 2622.69% |
| Revolution Medicines, Inc. | -430.58 Million USD | 538.308% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | 30109.143% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | 6229.705% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | 2630.198% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | -38392.25% |
| Anixa Biosciences, Inc. | -10.96 Million USD | 17311.81% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 59.019% |
| Denali Therapeutics Inc. | -179.97 Million USD | 1148.643% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 1982365.146% |
| Veru Inc. | -89.97 Million USD | 2197.541% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | 7121.635% |
| Cingulate Inc. | -22.95 Million USD | 8322.693% |
| Passage Bio, Inc. | -98.34 Million USD | 2019.113% |
| Context Therapeutics Inc. | -25.06 Million USD | 7630.854% |
| Exicure, Inc. | -15.53 Million USD | 12245.408% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 1015.868% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | 5204.054% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | 31751.901% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | 1220.284% |
| Nuvalent, Inc. | -149.49 Million USD | 1362.459% |
| ABVC BioPharma, Inc. | -8.13 Million USD | 23306.821% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | 2297.214% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | 6353.811% |
| OmniAb, Inc. | -49.73 Million USD | 3894.967% |
| Anew Medical, Inc. | -1.3 Million USD | 145181.255% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | 15364.275% |
| Lipocine Inc. | -16.32 Million USD | 11662.296% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | 2930.771% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | 2639.971% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 5049.163% |
| G1 Therapeutics, Inc. | -39.01 Million USD | 4937.43% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | 8607.754% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 446.245% |
| Ocugen, Inc. | -64.82 Million USD | 3011.248% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | 2138.754% |
| Q32 Bio Inc. | -86.5 Million USD | 2281.77% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | 11249.495% |
| Alumis Inc. Common Stock | -156.89 Million USD | 1302.929% |
| Equillium, Inc. | -12.13 Million USD | 15648.484% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | 3327.656% |
| Coya Therapeutics, Inc. | -7.9 Million USD | 23979.434% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | 10106.244% |
| Galera Therapeutics, Inc. | -46.69 Million USD | 4141.967% |
| Evelo Biosciences, Inc. | -106.34 Million USD | 1874.672% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | 10651.34% |
| Dominari Holdings Inc. | -22.44 Million USD | 8510.316% |
| Edesa Biotech, Inc. | -8.19 Million USD | 23143.251% |
| vTv Therapeutics Inc. | -25.41 Million USD | 7526.708% |
| Bio-Techne Corporation | 326.66 Million USD | -477.744% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 590.375% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | -772.168% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | 1539.481% |
| Candel Therapeutics, Inc. | -37.43 Million USD | 5142.011% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 1349.016% |
| Nkarta, Inc. | -120.48 Million USD | 1666.45% |
| BioCardia, Inc. | -11.56 Million USD | 16425.908% |
| Iterum Therapeutics plc | -34.58 Million USD | 5557.707% |